{
    "Trade/Device Name(s)": [
        "Diazyme Human Kappa (\u03ba) Free Light Chain Assay",
        "Diazyme Human Lambda (\u03bb) Free Light Chain Assay",
        "Diazyme Human Kappa and Lambda FLC Calibrator Set",
        "Diazyme Human Kappa and Lambda FLC Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K153394",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023009",
        "K023131",
        "K040009"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFH",
        "DEH"
    ],
    "Summary Letter Date": "October 28, 2016",
    "Summary Letter Received Date": "November 1, 2016",
    "Submission Date": "October 28, 2016",
    "Regulation Number(s)": [
        "21CFR866.5550"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (light chain specific) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Kappa Free Light Chain",
        "Lambda Free Light Chain"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Hitachi 917 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetric quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Human Kappa and Lambda Free Light Chain Assay and related calibrators/controls for quantitative serum measurement using latex enhanced immunoturbidimetric technology",
    "Indications for Use Summary": "Quantitative determination of Kappa and Lambda Free Light Chain concentrations in serum to aid in the diagnosis of multiple myeloma, used with Hitachi 917 analyzers and other laboratory findings for in vitro diagnostic use",
    "fda_folder": "Immunology"
}